CD86 and myeloid sarcoma: CD86 is an important co-stimulatory protein for T cell activation with increased expression in monocytes of MS patients and responsive to interferon treatment.46 Studies have shown that EBNA-2 may regulate several MS susceptibility loci, including the CD86 gene region affecting expression,3,25,47 perhaps modifying T cell activity and MS susceptibility.